BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29437696)

  • 1. Clinical Outcomes after Conservative Management of Cervical Intraepithelial Neoplasia Grade 2 (CIN2) in Women Ages 21-39 Years.
    Silver MI; Gage JC; Schiffman M; Fetterman B; Poitras NE; Lorey T; Cheung LC; Katki HA; Locke A; Kinney WK; Castle PE
    Cancer Prev Res (Phila); 2018 Mar; 11(3):165-170. PubMed ID: 29437696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia.
    Almog B; Gamzu R; Kuperminc MJ; Levin I; Fainaru O; Niv J; Bar-Am A
    Gynecol Oncol; 2003 Mar; 88(3):345-50. PubMed ID: 12648585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up testing after colposcopy: five-year risk of CIN 2+ after a colposcopic diagnosis of CIN 1 or less.
    Katki HA; Gage JC; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S69-77. PubMed ID: 23519308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus vaccination history and diagnosis of cervical intraepithelial neoplasia grade ≥2 severe lesions among a cohort of women who underwent colposcopy in Kaiser Permanente Southern California.
    Lonky NM; Xu L; Da Silva DM; Felix JC; Chao C
    Am J Obstet Gynecol; 2021 Dec; 225(6):656.e1-656.e11. PubMed ID: 34273278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of age and high-risk human papillomavirus (hrHPV) status on the prevalence of high-grade cervical intraepithelial neoplasia (CIN2+) in women with persistent hrHPV-positive, cytology-negative screening samples: a prospective cohort study.
    Tidy JA; Lyon R; Ellis K; Macdonald M; Palmer JE
    BJOG; 2020 Sep; 127(10):1260-1267. PubMed ID: 32279427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade CIN on cervical biopsy and predictors of the subsequent cone histology results in women undergoing immediate conization.
    Giannella L; Mfuta K; Gardini G; Rubino T; Fodero C; Prandi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():68-74. PubMed ID: 25656975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of guidelines for observational management of cervical intraepithelial neoplasia 2 in young women.
    Dempster-Rivett K; Innes CR; Simcock BJ; Harker D; Williman JA; Van Der Griend RA; Whitehead M; Hibma M; Lawton BA; Fitzgerald P; Dudley NM; Petrich S; Faherty J; Bergzoll C; Eva L; Sadler L; Pather S; Wrede CD; Sykes PH
    Am J Obstet Gynecol; 2020 Sep; 223(3):408.e1-408.e11. PubMed ID: 32109465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial.
    TOMBOLA Group
    BMJ; 2009 Jul; 339():b2546. PubMed ID: 19638646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up after treatment of high-grade cervical dysplasia: The utility of six-month colposcopy and cytology and routine 12-month colposcopy.
    Morton R; Mylvaganam G; Anderson L; Farrell R; Carter J; Pather S; Saidi S
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):959-964. PubMed ID: 32935336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term observational approach in women with histological diagnosis of cervical low-grade squamous intraepithelial lesion: an Italian multicentric retrospective cohort study.
    Ciavattini A; Serri M; Di Giuseppe J; Liverani CA; Gardella B; Papiccio M; Delli Carpini G; Morini S; Clemente N; Sopracordevole F
    BMJ Open; 2019 Jul; 9(7):e024920. PubMed ID: 31272971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative management of cervical intraepithelial neoplasia grade 2 (CIN2) in women under 30 years of age: A cohort study.
    Godfrey MAL; Nikolopoulos M; Garner JE; Adib TR; Mukhopadhyay D; Rains JS; Harper CA; Wuntakal R
    Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():267-273. PubMed ID: 30048921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: results of a long-term follow-up.
    Bar-Am A; Gamzu R; Levin I; Fainaru O; Niv J; Almog B
    Gynecol Oncol; 2003 Oct; 91(1):149-53. PubMed ID: 14529675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive.
    Katki HA; Schiffman M; Castle PE; Fetterman B; Poitras NE; Lorey T; Cheung LC; Raine-Bennett T; Gage JC; Kinney WK
    J Low Genit Tract Dis; 2013 Apr; 17(5 Suppl 1):S56-63. PubMed ID: 23519306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of high-grade cervical abnormalities following conservative management of cervical intraepithelial neoplasia grade 2.
    Wilkinson TM; Sykes PH; Simcock B; Petrich S
    Am J Obstet Gynecol; 2015 Jun; 212(6):769.e1-7. PubMed ID: 25582099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative management of women with cervical intraepithelial neoplasia grade 2 in Denmark: a cohort study.
    Skorstengaard M; Lynge E; Suhr J; Napolitano G
    BJOG; 2020 May; 127(6):729-736. PubMed ID: 31880054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immediate referral to colposcopy versus cytological surveillance for minor cervical cytological abnormalities in the absence of HPV test.
    Kyrgiou M; Kalliala IE; Mitra A; Fotopoulou C; Ghaem-Maghami S; Martin-Hirsch PP; Cruickshank M; Arbyn M; Paraskevaidis E
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD009836. PubMed ID: 28125861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative management of biopsy confirmed high-grade squamous intraepithelial lesions.
    Hederlingova J; Redman CW; Zahumensky J
    Bratisl Lek Listy; 2017; 118(12):732-735. PubMed ID: 29322804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.